These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 28874472)

  • 1. Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against
    Gao P; Davies J; Kao RYT
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874472
    [No Abstract]   [Full Text] [Related]  

  • 2. Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence.
    Chen F; Di H; Wang Y; Cao Q; Xu B; Zhang X; Yang N; Liu G; Yang CG; Xu Y; Jiang H; Lian F; Zhang N; Li J; Lan L
    Nat Chem Biol; 2016 Mar; 12(3):174-9. PubMed ID: 26780405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.
    Liu CI; Liu GY; Song Y; Yin F; Hensler ME; Jeng WY; Nizet V; Wang AH; Oldfield E
    Science; 2008 Mar; 319(5868):1391-4. PubMed ID: 18276850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections.
    Wang Y; Chen F; Di H; Xu Y; Xiao Q; Wang X; Wei H; Lu Y; Zhang L; Zhu J; Sheng C; Lan L; Li J
    J Med Chem; 2016 Apr; 59(7):3215-30. PubMed ID: 26999509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections.
    Wei H; Mao F; Ni S; Chen F; Li B; Qiu X; Hu L; Wang M; Zheng X; Zhu J; Lan L; Li J
    Eur J Med Chem; 2018 Feb; 145():235-251. PubMed ID: 29328999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A natural inhibitor of diapophytoene desaturase attenuates methicillin-resistant Staphylococcus aureus (MRSA) pathogenicity and overcomes drug-resistance.
    Han B; Wang H; Niu X
    Br J Pharmacol; 2024 Aug; 181(15):2583-2599. PubMed ID: 38604611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphyloxanthin inhibitory potential of thymol impairs antioxidant fitness, enhances neutrophil mediated killing and alters membrane fluidity of methicillin resistant Staphylococcus aureus.
    Valliammai A; Selvaraj A; Muthuramalingam P; Priya A; Ramesh M; Pandian SK
    Biomed Pharmacother; 2021 Sep; 141():111933. PubMed ID: 34328107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-Resistant S. aureus (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN).
    Wang Y; Di H; Chen F; Xu Y; Xiao Q; Wang X; Wei H; Lu Y; Zhang L; Zhu J; Lan L; Li J
    J Med Chem; 2016 May; 59(10):4831-48. PubMed ID: 27139780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiofilm and staphyloxanthin inhibitory potential of terbinafine against Staphylococcus aureus: in vitro and in vivo studies.
    Askoura M; Yousef N; Mansour B; Yehia FAA
    Ann Clin Microbiol Antimicrob; 2022 May; 21(1):21. PubMed ID: 35637481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hesperidin inhibits biofilm formation, virulence and staphyloxanthin synthesis in methicillin resistant Staphylococcus aureus by targeting SarA and CrtM: an in vitro and in silico approach.
    Vijayakumar K; Muhilvannan S; Arun Vignesh M
    World J Microbiol Biotechnol; 2022 Jan; 38(3):44. PubMed ID: 35064842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in
    Abbas HA; Elsherbini AM; Shaldam MA
    Afr Health Sci; 2019 Mar; 19(1):1376-1384. PubMed ID: 31148964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond conventional antibiotics for the future treatment of methicillin-resistant Staphylococcus aureus infections: two novel alternatives.
    Fitzgerald-Hughes D; Devocelle M; Humphreys H
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):399-412. PubMed ID: 22409572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalin Weakens
    Wang G; Gao Y; Wang H; Niu X; Wang J
    Front Cell Infect Microbiol; 2018; 8():418. PubMed ID: 30555803
    [No Abstract]   [Full Text] [Related]  

  • 14. Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections.
    Li B; Ni S; Chen F; Mao F; Wei H; Liu Y; Zhu J; Lan L; Li J
    ACS Infect Dis; 2018 Mar; 4(3):208-217. PubMed ID: 29377669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.
    Song Y; Liu CI; Lin FY; No JH; Hensler M; Liu YL; Jeng WY; Low J; Liu GY; Nizet V; Wang AH; Oldfield E
    J Med Chem; 2009 Jul; 52(13):3869-80. PubMed ID: 19456099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network analytics approach towards identifying potential antivirulence drug targets within the Staphylococcus aureus staphyloxanthin biosynthetic network.
    Cueno ME; Imai K
    Arch Biochem Biophys; 2018 May; 645():81-86. PubMed ID: 29551420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characteristics and virulence gene profiles of Staphylococcus aureus isolates in Hainan, China.
    Li X; Huang T; Xu K; Li C; Li Y
    BMC Infect Dis; 2019 Oct; 19(1):873. PubMed ID: 31640587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus.
    Kahlon AK; Roy S; Sharma A
    J Biomol Struct Dyn; 2010 Oct; 28(2):201-10. PubMed ID: 20645653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule compound SYG-180-2-2 attenuates
    Rao L; Xu Y; Shen L; Wang X; Zhao H; Wang B; Zhang J; Xiao Y; Guo Y; Sheng Y; Cheng L; Song Z; Yu F
    Front Cell Infect Microbiol; 2022; 12():1008289. PubMed ID: 36310881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity and virulence of
    Cheung GYC; Bae JS; Otto M
    Virulence; 2021 Dec; 12(1):547-569. PubMed ID: 33522395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.